ImpactAlpha, May 15 – More than 80,000 people have signed up to purchase affordable, high quality medicine and health products from Nairobi-based MYDAWA. The firm raised $3 million from Africa HealthCare Master Fund in its first external round of funding.
“Our goal at MYDAWA has always been to be trusted partner for busy Kenyans by providing convenient, private access to authentic medication and wellness products at very good value,” said MYDAWA founder Neil O’Leary. The company will use the funds to roll-out cross Kendya.
MYDAWA sources from manufacturers and drug producers approved the World Health Organisation. Users authenticate products using via text message or QR code.
Africa HealthCare Master Fund is an African health fund of Singapore investment firm Asia Africa Investment and Consulting. Other fund investments include affordable dialysis chain Africa Health Network, emergency response startup Flare and Jumuia Hospitals.